Cited by 162Liver Disease Diagnosis and TreatmentLiver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Caspase 3 Inactivation Protects Against Hepatic Cell Death and Ameliorates Fibrogenesis in a Diet-Induced NASH Model

Open access

Thapaliya, Samjhana, Wree, Alexander, Povero, Davide, Inzaugarat, Maria Eugenia, Berk, Michael, Dixon, Laura, Papouchado, Bettina G., Feldstein, Ariel E.·2014·Digestive Diseases and Sciences

DOI 10.1007/s10620-014-3167-6PMC PMC4512760

Open this paper in CoChat — free account

Abstract

Background/aims Hepatocyte cell death is a key feature of nonalcoholic steatohepatitis (NASH). As the contribution of specific caspases remains unclear, our aim was to ascertain the effect of caspase 3 suppression on liver injury and fibrogenesis. Methods C57BL/6 wild-type (WT) and caspase 3 knock out (Casp3 (-/-)) mice were placed on a methionine- and choline-deficient (MCD) diet for 6 weeks to induce steatohepatitis and liver fibrosis. Thereafter, liver injury, liver fibrosis and hepatocellular apoptosis were quantified in liver sections. Additionally, expression of proteins associated with liver inflammation and fibrogenesis was analyzed. Results WT mice fed MCD diet showed marked activation of caspase 3 in hepatocytes, in conjunction with steatohepatitis and increased hepatic triglyceride levels, hepatocyte ballooning, inflammation and fibrosis. Casp3 (-/-) mice fed the MCD diet showed similar serum aminotransferase levels and NAFLD activity scores (NAS) compared with WT MCD-fed mice. However, Casp3 (-/-) mice on the MCD diet showed a marked reduction in expression of transcripts for profibrogenic genes, which translated into reduced hepatic collagen deposition. These changes were associated with decreased levels of apoptosis, and a significant reduction in the expression of cytokines involved in inflammatory signaling. Casp3 (-/-) mice on the MCD showed a reduction in expression of chemokine receptor 2 (CCR2) leading to ameliorated infiltration of inflammatory lymphocyte antigen 6 complex, locus C1 (Ly6c) positive monocytes. Conclusion These findings support a prominent role for hepatocyte caspase 3 activation in NASH-related apoptosis, fibrogenesis and fibrosis which in part is mediated via CCR2-dependent infiltration of Ly6c positive monocytes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s10620-014-3167-6

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Self-citation
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Earnshaw, W. C., Martins, L. M., & Kaufmann, S. H. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.383 · Cited by 2,758
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658
Prevalence of Fatty Liver in Children and Adolescents
Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C. R., & Behling, C. A. (2006) · PEDIATRICS · doi:10.1542/peds.2006-1212 · Cited by 1,477
Caspases in apoptosis and beyond
Li, J., & Yuan, J. (2008) · Oncogene · doi:10.1038/onc.2008.297 · Cited by 1,090

Flagged first, then by citations

Show all 42 references

1 of the 42 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–162 of 162

Every-other day (EOD) feeding regime decreases oxidative stress and inflammatory cascade in mouse liver: The immunohistochemical study
Piotrowska, K., Zgutka, K., Tomasiak, P., Tarnowski, M., & Pawlik, A. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102236 · Cited by 4
Computational dissection through network pharmacology and structure-based analysis unravels mechanistic actions of bioactive compounds in a hepatoprotective herb, Picrorhiza kurroa for the treatment of NAFLD and NASH
Sharma, S., Sharma, A., & Chauhan, R. S. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2438358 · Cited by 4
Ultra‐high‐performance liquid chromatography‐quadrupole time‐of‐flight‐mass spectrometry‐characterized extract of Aerides odorata Lour alleviates paracetamol‐induced hepatotoxicity in animal model evidenced by biochemical, molecular, and computational studies
Ahmed, A. M. A., Rahman, M. A., Sharmen, F., Reza, A. S. M. A., Islam, M. S., Rashid, M. M., Rafi, M. K. J., Siddique, T. A., Ezaj, M. M. A., Saha, S., et al. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12452 · Cited by 4
Immune neutralization of the receptor for advanced glycation end products reduce liver oxidative damage induced by an acute systemic injection of lipopolysaccharide
Ribeiro, C. T., Gasparotto, J., Teixeira, A. A., Portela, L. V., Louzada-Flores, V. N., Moreira, J. C. F., & Gelain, D. P. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvy013 · Cited by 4
INFLUENCE OF SELENIUM ON MONO SODIUM GLUTAMATE AS FOOD ADDITIVE INDUCED HEPATOTOXICITY AND TESTICULAR TOXICITY IN ADULT ALBINO RATS
Khayal, E., Mohammed, Z. A., & Ahmed, M. M. (2018) · The Egyptian Journal of Forensic Sciences and Applied Toxicology · doi:10.21608/ejfsat.2018.4459.1018 · Cited by 4
Combination of THU/ALK-5i exhibits profound anti-MASH activity through suppression of lipogenesis and fibrogenesis
Boonloh, K., Lee, E. Y., Jo, S. H., Park, N. W., Lee, S. B., & Chung, C. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-23626-3 · Cited by 3
Validating hepatoprotective potency of caffeic acid targeting BCL-2/Caspase-3 axis against endotoxin-driven liver toxicity: an in vivo and in silico approach
Yadav, A., & Mohanty, B. (2025) · Nutrire · doi:10.1186/s41110-025-00403-w · Cited by 3
Humanized monoacylglycerol acyltransferase 2 mice develop metabolic dysfunction-associated steatohepatitis
Corbalan, J. J., Jagadeesan, P., Frietze, K. K., Taylor, R. E., Gao, G. L., Gallagher, G., & Nickels, J. T. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100695 · Cited by 3
Mesenchymal stem cell and exosome-based therapy for liver diseases: can it overcome conventional therapeutic inconsistencies?
Hussain, Z. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100563 · Cited by 3
Active Compounds Screening and Hepatoprotective Mechanism of Shuganning Injection Based on Network Pharmacology and Experimental Validation
Wang, Q., Duan, X., Li, S., Lai, H., Cheng, W., Ao, J., Zhang, J., & Duan, C. (2022) · Natural Product Communications · doi:10.1177/1934578x221124756 · Cited by 3
Neonatal nicotine exposure affects adult rat hepatic pathways involved in endoplasmic reticulum stress and macroautophagy in a sex-dependent manner
Souza, L. L., Rossetti, C. L., Peixoto, T. C., Manhães, A. C., de Moura, E. G., & Lisboa, P. C. (2023) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174423000326 · Cited by 3
Pharmacological Evaluation of Araliadiol as a Novel Anti-Inflammatory Agent in LPS-Induced RAW 264.7 Cells
Park, S., Cho, S., Shin, H.-J., Baek, S., Gwon, H.-I., Lee, J., Yoo, D. S., Park, H. W., Seo, D. B., & Bae, S. (2025) · Biomedicines · doi:10.3390/biomedicines13061408 · Cited by 4
Model for Non-Invasive Diagnosis of NAFLD Incorporating Caspase 3-Cleaved Cytokeratin-18: A Clinical, Serological, and Immunohistochemical Analysis
Elalfy, H., Besheer, T. A., Elhammady, D., Mohamed, M. A., El-Hussiny, M. A.-B., Elkashef, W. F., Eldeek, B. S., & Alsayed, S. A. M. (2018) · Hepatitis Monthly · doi:10.5812/hepatmon.60168 · Cited by 3
The Metabolic Sensor Adenosine Monophosphate–Activated Protein Kinase Regulates Apoptosis in Nonalcoholic Steatohepatitis
Guicciardi, M. E., Nakao, Y., Gores, G. J., et al. (2020) · Hepatology · doi:10.1002/hep.31294 · Cited by 3
Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis
Klaikeaw, N., Wongphoom, J., Werawatganon, D., Chayanupatkul, M., & Siriviriyakul, P. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i7.364 · Cited by 3
The Caspase Family of Proteases
Puccini, J., & Kumar, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00190-5 · Cited by 3
HES5-mediated repression of LIGHT transcription may contribute to apoptosis in hepatocytes
Miao, X.-L., Guo, Y., Zeng, S., Liu, X., Teng, X.-H., Li, L.-Y., & Hong, W. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00707-6 · Cited by 2
Quercetin: a natural remedy against high-fat diet-induced liver steatosis in Oncorhynchus mykiss
Köse, Ö. (2025) · Frontiers in Marine Science · doi:10.3389/fmars.2025.1656703 · Cited by 2
Combinatorial Therapeutic Potential of Stem Cells and Benzimidazol Derivatives for the Reduction of Liver Fibrosis
Iqbal, M., Shams, S., Rafiq, H., Khan, M., Khan, S. U., Khattak, U. S., Afridi, S. G., Bibi, F., Abdulkareem, A. A., & Naseer, M. I. (2023) · Pharmaceuticals · doi:10.3390/ph16020306 · Cited by 2
Passion Fruit Seed Extract Attenuates Hepatic Steatosis in Oleic Acid-Treated HepG2 Cells through Modulation of ERK1/2 and Akt Signaling Pathways
Moolsup, F., Suttithumsatid, W., Woonnoi, W., Chonpathompikunlert, P., Tanasawet, S., & Sukketsiri, W. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01706-5 · Cited by 2
The impact of leptin receptor (LepR) mutation on the development of MASLD in a murine model
Arindkar, S., Singh, S., Kumar, J. M., & Nagarajan, P. (2025) · Gene · doi:10.1016/j.gene.2025.149550 · Cited by 2
Disruption of Hepatic Sinusoidal Homeostasis Leads to Hepatopulmonary Syndrome
Chen, J., Guo, Y., Zhang, X., Zhou, D., Zhou, Y., Pan, Q., Chai, J., & Gao, J. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70585 · Cited by 2
Genome-Based Mexican Diet Bioactives Target Molecular Pathways in HBV, HCV, and MASLD: A Bioinformatic Approach for Liver Disease Prevention
Leal-Mercado, L., Panduro, A., José-Ábrego, A., & Román, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188977 · Cited by 2
Modeling the LPS-induced effects on transcription factor activation and gene expression in murine macrophages
Sanwald, J., Albrecht, U., Wagenpfeil, J., Thomas, M., Sawodny, O., Bode, J. G., & Feuer, R. (2015) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2015.7319268 · Cited by 2
Гліциризинова кислота: патофізіологічні аспекти формування фіброзу та ефективність у лікуванні захворювань печінки
Stepanov, Y. М., Yagmur, V. B., & Саленко, А. В. (2018) · GASTROENTEROLOGY · doi:10.22141/2308-2097.52.3.2018.141846 · Cited by 2
Programmed cell death and liver diseases
Онищенко, Н. А., Гоникова, З. З., Nikolskaya, A. O., Кирсанова, Л. А., & Sevastianov, V. I. (2022) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2022-1-72-88 · Cited by 3
Exploration of the pharmacological mechanism of herbal medicines against hepatic disorder: A systematic review and network pharmacological analysis
Sarkar, S., Das, M., & Nanjappan, S. K. (2024) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2024.100048 · Cited by 2
Mechanistic Biomarkers in Liver Diseases
McGill, M. R., Woolbright, B. L., Weemhoff, J. L., & Jaeschke, H. (2016) · Exposure and Health · doi:10.1007/978-94-007-7742-2_5-1 · Cited by 2
Based on the Pharmacology and Molecular Docking of Traditional Chinese Medicine Network, the Components and Mechanism of Action of Safflower in the Prevention and Treatment of Liver Fibrosis Were Studied
彭, 松. (2023) · Traditional Chinese Medicine · doi:10.12677/tcm.2023.127272 · Cited by 1
Towards novel liver injury therapies based on design, synthesis and therapeutic efficacy of novel sulfone bis-compound on liver necrosis
Rashdan, H. R. M., Hassan, S., Maher, S., & Okasha, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-02483-0 · Cited by 1
Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation, oxidative/nitrative stress, apoptosis and fibrosis
Hassan, F. E., Hassanien, M. M., Selmy, A., Mahmoud, L. M., Darwish, A., & Aldreny, B. A. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2025.1752370 · Cited by 1
Dietary silymarin effectively alleviated fumonisin B1-induced hepatopancreatic steatosis and fibrosis in juvenile grass carp (Ctenopharyngodon idella)
Chen, D., Jiang, W., Wu, P., Liu, Y., Ma, Y., Zhang, H., Ren, H., Jin, X., Zhou, X., & Feng, L. (2026) · Marine Life Science & Technology · doi:10.1007/s42995-025-00349-y · Cited by 1
Effects of Ventilation During Warm Ischemia in a Rat Lung Perfusion Model
Ramos, M. M. D. A., Pedroso, L. D. S., Ramos, I. Y. T., da Anunciação, L. F., Ricardo‐da‐Silva, F. Y., Correia, C. D. J., Moreira, L. F. P., Leuvenink, H. G. D., & Breithaupt‐Faloppa, A. C. (2026) · Journal of Surgical Research · doi:10.1016/j.jss.2026.02.014 · Cited by 1
Study on the Mechanism of Zhenwu Decoction in Decreasing the Fats in Non-Alcoholic Fatty Liver Disease Using System Pharmacology and Cytological Validation Test
Zhang, C. J., Fang, Z. Y., Tang, Y. Q., Zheng, L., Zhu, H., Huang, L., Xia, L.-Y., Huai, W. Y., Yin, Q. Z., Wang, Y. Q., et al. (2022) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.526 · Cited by 1
Renoprotective Role of Thymol-loaded Chitosan Nanoparticles in Cholestatic Rats
Kamel, T. A., Baiomy, A. A. A., Qutb, S. A., & Mohamed, A. S. (2025) · Current Chemical Biology · doi:10.2174/0122127968401483251014085241 · Cited by 1
From fatty liver to nonalcoholic steatohepatitis with fibrosis
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00013-5 · Cited by 1
Exploring the Mechanism of Danggui Shaoyao San in the treatment of Non-alcoholic Fatty Liver Disease: A Study based on Network Pharmacology and Molecular DockingPreprint
Xia, L.-Y., Luo, Z., Zhu, H., Tang, Y., Huang, L., Huai, W., Zhang, C., Wang, Y., Fang, Z., Yin, Q., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1216657/v1 · Cited by 1
BAG6 is a novel player in controlling nonalcoholic steatohepatitis: result from a comprehensive in-silico studyPreprint
Sarmah, D. T., Paul, A., Berry, U., Surjit, M., Bairagi, N., & Chatterjee, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.04.539506 · Cited by 1
Possible role of angiogenesis suppression in rats model of non alcoholic fatty liver disease
Rezk, D. A. G., sarhan, M., Abd-Elmoniem, H. A., abbas, A., & salama, M. (2019) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2019.4410.1004
From inflammation to fibrosis
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00010-x
CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in non-alcoholic steatohepatitis micePreprint
Masuda, A., Nakamura, T., Iwamoto, H., Suzuki, H., Sakaue, T., Tanaka, T., Imamura, Y., Mori, N., Koga, H., & Kawaguchi, T. (2023) · Research Square · doi:10.21203/rs.3.rs-3155319/v1
Serum level of proteins involved in apoptosis and autophagy in patients with type 2 diabetes and non-alcoholic fatty liver disease
Krasner, Y. A., Romanov, V. V., Fazullina, O. N., Осипенко, М. Ф., & Klimontov, V. V. (2024) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20230618
Lack of Nr2e1 expression in hepatocytes impaired cell survival and aggravated palmitate-induced oxidative stress
Xiong, Q., Wang, H., Feng, J., Song, L., Wu, G., & Xu, Y. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.06.002
Non-alcoholic steatohepatitis
Pinheiro, M. M., Afonso, M. B., & Rodrigues, C. M. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00003-4
Lasting Multiorgan Protective Effect of Stem Cells in Systemic Endotoxaemia
Abdel‐Salam, O. M. E., Omara, E. A. A., Youness, E. R., & Sleem, A. A. (2025) · MOLECULAR SCIENCES AND APPLICATIONS · doi:10.37394/232023.2025.5.10
Additional file 2 of A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet
Suzuki‐Kemuriyama, N., Abe, A., Uno, K., Ogawa, S., Watanabe, A., Sano, R., Yuki, M., Miyajima, K., & Nakae, D. (2020) · Figshare · doi:10.6084/m9.figshare.13467717
Additional file 3 of A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet
Suzuki‐Kemuriyama, N., Abe, A., Uno, K., Ogawa, S., Watanabe, A., Sano, R., Yuki, M., Miyajima, K., & Nakae, D. (2020) · Figshare · doi:10.6084/m9.figshare.13467719
Additional file 5 of A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet
Suzuki‐Kemuriyama, N., Abe, A., Uno, K., Ogawa, S., Watanabe, A., Sano, R., Yuki, M., Miyajima, K., & Nakae, D. (2020) · Figshare · doi:10.6084/m9.figshare.13467723
Additional file 6 of A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet
Suzuki‐Kemuriyama, N., Abe, A., Uno, K., Ogawa, S., Watanabe, A., Sano, R., Yuki, M., Miyajima, K., & Nakae, D. (2020) · Figshare · doi:10.6084/m9.figshare.13467725
Additional file 7 of A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet
Suzuki‐Kemuriyama, N., Abe, A., Uno, K., Ogawa, S., Watanabe, A., Sano, R., Yuki, M., Miyajima, K., & Nakae, D. (2020) · Figshare · doi:10.6084/m9.figshare.13467727
Additional file 1 of A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet
Suzuki‐Kemuriyama, N., Abe, A., Uno, K., Ogawa, S., Watanabe, A., Sano, R., Yuki, M., Miyajima, K., & Nakae, D. (2020) · Figshare · doi:10.6084/m9.figshare.13467715
Hepatotoxic Effects of Gasoline Fumes in Male Albino Rats: Evidence from Pro-Inflammatory Cytokine Expression and Apoptotic Marker Activation
Osibogun, A., Owagboriaye, F. O., Ariyibi, M., Adeyemi, J. A., Busari, A., Ordu, J., Adekunle, O. N., Adeleke, M. T., Salisu, T. F., Oladunjoye, R. Y., et al. (2026) · University of Zambia Journal of Agricultural and Biomedical Sciences · doi:10.53974/unza.jabs.10.1.1502
Combining UHPLC profiling and random walk network-based in vitro analysis to predict herb-induced liver injury
Choi, K., Park, J. Y., Yoo, S., Park, S.-Y., Han, H., & Kim, J. Y. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116050
Identification of disease ameliorated metabolite candidates from Gut Microbes and their interacting targets based on a novel estimating function
Cui, H., Liao, Z., Kuang, X., Zhang, J., Song, C.-Y., Liu, Y.-J., Cheng, Z., Deng, Z., & Guo, F.-B. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1770840
Rôle du facteur de transcription circadien Krüppel-Like Factor 10 (KLF 10) dans le développement des complications hépatiques de l’obésité
Leclère, P. S. (2019) · theses.fr (ABES) · doi:10.70675/7a3e667czbdf7z4068zbadfzd850044a706a
Role of RIPK1 in the survival and death of hepatocytes : its involvement in murine hepatitis models
Farooq, M. (2019) · theses.fr (ABES) · doi:10.70675/5fe7950dz1147z4d64z9b9bz87bfd1d3ae35
The functional role of Claudin-1 as a mediator and therapeutic target in liver fibrogenesis and hepatocarcinogenesis
Roehlen, N. (2021) · theses.fr (ABES) · doi:10.70675/f74abe25z2801z481cza9b8zb9232964c1fa
La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
Majdi, A. (2020) · theses.fr (ABES) · doi:10.70675/94f28bbaz6c2dz4b48zb1aaze6b48ca72708
Rôle de REG3A dans la maladie métabolique du foie d'origine nutritionnelle
Nguyen, T.-S. (2024) · theses.fr (ABES) · doi:10.70675/2c0ffdcfz96ccz43b0z8e03zb358f83e528d
Design and synthesis of new curcumin analogues as hepatoprotectives and antioxidants in liver dysfunction through caspase-3 regulation
Zaher, N. H., Mostafa, M. I., & El-Gazzar, M. G. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2676783
Investigating the role of ferroptosis in the pathogenesis of murine models of metabolic dysfunction-associated steatohepatitis (MASH)Preprint
TANAKA, M., Kijima, M., Kanegae, K., Tsurusaki, S., Kok, C., Tanaka, M., & Nakano, H. (2026) · Research Square · doi:10.21203/rs.3.rs-9598743/v1
Investigation of the healing effects of phenylboronic acid and exosome on the TGF-β-Smad/REDD1 pathway in aspartame-induced liver damage in BALB/c type mice
Sahin, B., Acar, T. Y., Kurt, A., Cebeci, B., & Keskin, İ. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119788

Authors: Thapaliya, S., Wree, A., Povero, D., Inzaugarat, M. E., Berk, M., Dixon, L., Papouchado, B. G., & Feldstein, A. E.
Affiliations: Cleveland Clinic (US)
University of California San Diego (US)
Corresponding author: Feldstein, Ariel E.
ORCID: Thapaliya, Samjhana
Wree, Alexander
Povero, Davide
Berk, Michael
Feldstein, Ariel E.
Venue: Digestive Diseases and Sciences
Publisher: Springer Science and Business Media LLC
Published: 2014-05-03
Volume: 59
Issue: 6
Pages: 1197-1206
ISSN: 0163-2116 (ISSN-L)
1573-2568
DOI: 10.1007/s10620-014-3167-6
PMC: PMC4512760
OpenAlex: W2040177711
Cited by: 162
References: 42
Citations by year: 2026: 9 · 2025: 24 · 2024: 17 · 2023: 20 · 2022: 13 · 2021: 10 · 2020: 18 · 2019: 16 · 2018: 14 · 2017: 8 · 2016: 5 · 2015: 7 · 2014: 1
FWCI: 5.30
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Digestive Diseases and Sciences (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: University of Toronto
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082451, R01DK076852, DK082451, DK-076852)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords: caspase-3, nonalcoholic steatohepatitis, liver fibrosis, hepatocyte apoptosis, methionine-choline-deficient diet, CCR2, Ly6C+ monocytes, monocyte infiltration, liver inflammation, hepatic steatosis
MeSH terms: Animals, Antigens, Ly, Choline, Collagen, Dose-Response Relationship, Drug, Fatty Liver, Gene Expression Regulation, Liver Cirrhosis, Methionine, Mice, Inbred C57BL, Apoptosis, Mice, Knockout, Hepatocytes, Mice, Caspase 3, Receptors, CCR2, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Caspase 3 Inactivation Protects Against Hepatic Cell Death and Ameliorates Fibrogenesis in a Diet-Induced NASH Model

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks